Literature DB >> 20695174

A brief history of malaria chemotherapy.

A R Butler1, S Khan, E Ferguson.   

Abstract

Malaria is one of the worst sicknesses to affect humankind. For centuries there was no specific treatment, and it was not until the seventeenth century that Spanish colonisers brought back from Peru tree bark from which quinine was later extracted. In the twentieth century, synthetic alternatives to quinine were developed. Of these, chloroquine was the most successful, but by the 1970s widespread resistance had developed and the world was left without an effective treatment for malaria. During the same decade Chinese scientists extracted from sweet wormwood plant the drug artemisinin, which has proved to be very effective against chloroquine-resistant malarial parasites. The use of a combination therapy including artemisinin has made it possible to contemplate the eradication of malaria. Efforts to produce a stable and inexpensive supply of artemisinin are under way.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20695174     DOI: 10.4997/jrcpe.2010.216

Source DB:  PubMed          Journal:  J R Coll Physicians Edinb        ISSN: 1478-2715


  7 in total

Review 1.  Nanomedicines for Malaria Chemotherapy: Encapsulation vs. Polymer Therapeutics.

Authors:  Sindisiwe Mvango; William M R Matshe; Abideen O Balogun; Lynne A Pilcher; Mohammed O Balogun
Journal:  Pharm Res       Date:  2018-10-15       Impact factor: 4.200

2.  Responding to the evidence for the management of severe malaria.

Authors:  Nathan P Ford; Martin de Smet; Kavitha Kolappa; Nicholas J White
Journal:  Trop Med Int Health       Date:  2011-06-20       Impact factor: 2.622

3.  How feedback biases give ineffective medical treatments a good reputation.

Authors:  Mícheál de Barra; Kimmo Eriksson; Pontus Strimling
Journal:  J Med Internet Res       Date:  2014-08-21       Impact factor: 5.428

4.  Post-marketing surveillance of anti-malarial medicines used in Malawi.

Authors:  Ibrahim Chikowe; Dorcas Osei-Safo; Jerry J E K Harrison; Daniel Y Konadu; Ivan Addae-Mensah
Journal:  Malar J       Date:  2015-03-25       Impact factor: 2.979

5.  Characterization of the commercially-available fluorescent chloroquine-BODIPY conjugate, LynxTag-CQGREEN, as a marker for chloroquine resistance and uptake in a 96-well plate assay.

Authors:  Cheryl C Y Loh; Rossarin Suwanarusk; Yan Quan Lee; Kitti W K Chan; Kit-Ying Choy; Laurent Rénia; Bruce Russell; Martin J Lear; François H Nosten; Kevin S W Tan; Larry M C Chow
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

6.  Historical trends and new surveillance of Plasmodium falciparum drug resistance markers in Angola.

Authors:  Emily R Ebel; Fátima Reis; Dmitri A Petrov; Sandra Beleza
Journal:  Malar J       Date:  2021-04-07       Impact factor: 2.979

7.  Lead Optimization of Dehydroemetine for Repositioned Use in Malaria.

Authors:  Priyanka Panwar; Kepa K Burusco; Muna Abubaker; Holly Matthews; Andrey Gutnov; Elena Fernández-Álvaro; Richard A Bryce; James Wilkinson; Niroshini Nirmalan
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.